SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001399529-19-000026
Filing Date
2019-08-08
Accepted
2019-08-08 16:11:17
Documents
3
Period of Report
2019-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drna-20190809x8k.htm 8-K 30323
2 EXHIBIT 99.1 drna-20190809xex991.htm EX-99.1 121503
3 dicernareports1q19.jpg GRAPHIC 22788
  Complete submission text file 0001399529-19-000026.txt   184455
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 191009610
SIC: 2834 Pharmaceutical Preparations